Temat: "Radiopharmaceuticals" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Stabilization Strategies for Linear Minigastrin Analogues: Further Improvements via the Inclusion of Proline into the Peptide Sequence.
Autorzy :: Klingler M; Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Hörmann AA; Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Rangger C; Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Desrues L; INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen Normandy, 76000 Rouen, France.
Castel H; INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen Normandy, 76000 Rouen, France.
Gandolfo P; INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), University of Rouen Normandy, 76000 Rouen, France.
von Guggenberg E; Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.; Pokaż więcej
Źródło :: Journal of medicinal chemistry [J Med Chem] 2020 Dec 10; Vol. 63 (23), pp. 14668-14679. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Gastrins/*metabolism
Heterocyclic Compounds, 1-Ring/*metabolism
Proline/*chemistry
Radiopharmaceuticals/*metabolism
Amino Acid Sequence ; Animals ; Cell Line, Tumor ; Drug Stability ; Female ; Gastrins/chemical synthesis ; Gastrins/pharmacokinetics ; Heterocyclic Compounds, 1-Ring/chemical synthesis ; Heterocyclic Compounds, 1-Ring/pharmacokinetics ; Humans ; Indium Radioisotopes/chemistry ; Lutetium/chemistry ; Mice, Inbred BALB C ; Protein Binding ; Radioisotopes/chemistry ; Radiopharmaceuticals/chemical synthesis ; Radiopharmaceuticals/pharmacokinetics ; Rats ; Receptor, Cholecystokinin B/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Preliminary biological evaluation of 123I-labelled anti-CD30-LDM in CD30-positive lymphomas murine models.
Autorzy :: Gong J; NHC Key Laboratory of Biotechnology of Antibiotics, Laboratory of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guo F; High Tech of Atom Co. Ltd, Beijing, China.
Cheng W; High Tech of Atom Co. Ltd, Beijing, China.
Fan H; High Tech of Atom Co. Ltd, Beijing, China.
Miao Q; NHC Key Laboratory of Biotechnology of Antibiotics, Laboratory of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang J; Nuclear Medicine Department, Beijing Friendship Hospital, Affiliated to Capital Medical University, Beijing, China.; Pokaż więcej
Źródło :: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2020 Dec; Vol. 48 (1), pp. 408-414.
Typ publikacji :: Journal Article; Video-Audio Media
MeSH Terms :: Antineoplastic Agents, Immunological*/chemistry
Antineoplastic Agents, Immunological*/pharmacokinetics
Antineoplastic Agents, Immunological*/pharmacology
Iodine Radioisotopes*/chemistry
Iodine Radioisotopes*/pharmacokinetics
Iodine Radioisotopes*/pharmacology
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, Large-Cell, Anaplastic*/metabolism
Lymphoma, Large-Cell, Anaplastic*/pathology
Radiopharmaceuticals*/chemistry
Radiopharmaceuticals*/pharmacokinetics
Radiopharmaceuticals*/pharmacology
Ki-1 Antigen/*antagonists & inhibitors
Neoplasm Proteins/*antagonists & inhibitors
Animals ; Humans ; Mice ; Neoplasms, Experimental/drug therapy ; Neoplasms, Experimental/metabolism ; Neoplasms, Experimental/pathology ; Xenograft Model Antitumor Assays
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Prospective Study of Systemic Yttrium-90 Elution during Radioembolization of Hepatic Metastases.
Autorzy :: Alexander ES; Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St., 1 Founders, MRI Education Center, Philadelphia, PA 19104. Electronic address: .
Pantel AR; Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St., 1 Founders, MRI Education Center, Philadelphia, PA 19104.
Carlin SD; Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St., 1 Founders, MRI Education Center, Philadelphia, PA 19104.
Beckmann N; Environmental Health and Radiation Safety, University of Pennsylvania, Philadelphia, Pennsylvania.
Mick R; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Pryma DA; Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St., 1 Founders, MRI Education Center, Philadelphia, PA 19104.
Soulen MC; Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St., 1 Founders, MRI Education Center, Philadelphia, PA 19104.; Pokaż więcej
Źródło :: Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2020 Dec; Vol. 31 (12), pp. 2007-2013.e1. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Embolization, Therapeutic*/adverse effects
Radiation Dosage*
Liver Neoplasms/*radiotherapy
Radiopharmaceuticals/*administration & dosage
Yttrium Radioisotopes/*administration & dosage
Adult ; Aged ; Female ; Humans ; Liver Neoplasms/diagnostic imaging ; Liver Neoplasms/secondary ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies ; Radiopharmaceuticals/adverse effects ; Radiopharmaceuticals/blood ; Time Factors ; Treatment Outcome ; Yttrium Radioisotopes/adverse effects ; Yttrium Radioisotopes/blood
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Point-An Important Diagnostic, Phenotypic, and Biomarker Role.
Autorzy :: Calais J; Department of Molecular and Medical Pharmacology, Ahmanson Translational Theranostics Division, David Geffen School of Medicine, University of California Los Angeles, 200 Medical Plaza, Ste B114-61, Los Angeles, CA 90095.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA.; Physics and Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA.
Mona CE; Department of Molecular and Medical Pharmacology, Ahmanson Translational Theranostics Division, David Geffen School of Medicine, University of California Los Angeles, 200 Medical Plaza, Ste B114-61, Los Angeles, CA 90095.; Pokaż więcej
Źródło :: AJR. American journal of roentgenology [AJR Am J Roentgenol] 2021 Feb; Vol. 216 (2), pp. 305-306. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :: Journal Article
MeSH Terms :: Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals*
Gelatinases/*antagonists & inhibitors
Gelatinases/*metabolism
Membrane Proteins/*antagonists & inhibitors
Membrane Proteins/*metabolism
Neoplasms/*diagnostic imaging
Serine Endopeptidases/*metabolism
Biomarkers/metabolism ; Humans ; Neoplasms/metabolism ; Sensitivity and Specificity
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Creation.
Autorzy :: Gordon AC; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.
Gupta AN; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.
Gabr A; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.
Thornburg BG; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.
Kulik LM; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois; Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois.
Ganger DR; Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois.
Maddur H; Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois.
Flamm SL; Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois.
Boike JR; Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois.
Moore CM; Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois.
Borja-Cacho D; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois.
Christopher DA; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois.
Katariya NN; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois.
Ladner DP; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois; Department of Medical Social Sciences, Northwestern University, Chicago, Illinois.
Caicedo-Ramirez JC; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois.
Riaz A; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.
Salem R; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois; Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois.
Lewandowski RJ; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois; Division of Transplant Surgery, Department of Surgery, Northwestern University, Chicago, Illinois; Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, Illinois. Electronic address: .; Pokaż więcej
Źródło :: Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2021 Feb; Vol. 32 (2), pp. 211-219. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :: Journal Article
MeSH Terms :: Embolization, Therapeutic*/adverse effects
Embolization, Therapeutic*/mortality
Portasystemic Shunt, Transjugular Intrahepatic*/adverse effects
Portasystemic Shunt, Transjugular Intrahepatic*/mortality
Carcinoma, Hepatocellular/*therapy
Liver Neoplasms/*therapy
Radiopharmaceuticals/*administration & dosage
Yttrium Radioisotopes/*administration & dosage
Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/diagnostic imaging ; Carcinoma, Hepatocellular/mortality ; Databases, Factual ; Disease Progression ; Female ; Humans ; Liver Neoplasms/diagnostic imaging ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Radiopharmaceuticals/adverse effects ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Yttrium Radioisotopes/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Diagnostic Accuracy of Amyloid versus F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia.
Autorzy :: Lesman-Segev OH; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Israel.
La Joie R; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Iaccarino L; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Lobach I; Epidemiology and Biostatistics Department, University of California, San Francisco, San Francisco, CA, USA.
Rosen HJ; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Seo SW; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Janabi M; Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Baker SL; Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Edwards L; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Pham J; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Olichney J; Alzheimer's Disease Center, Department of Neurology, University of California, Davis, Sacramento, CA, USA.
Boxer A; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Huang E; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Gorno-Tempini M; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
DeCarli C; Alzheimer's Disease Center, Department of Neurology, University of California, Davis, Sacramento, CA, USA.
Hepker M; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Hwang JL; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Miller BL; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Spina S; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Grinberg LT; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Seeley WW; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Jagust WJ; Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.; Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA, USA.
Rabinovici GD; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Alzheimer's Disease Center, Department of Neurology, University of California, Davis, Sacramento, CA, USA.; Departments of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA.; Pokaż więcej
Źródło :: Annals of neurology [Ann Neurol] 2021 Feb; Vol. 89 (2), pp. 389-401. Date of Electronic Publication: 2020 Dec 07.
Typ publikacji :: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Aniline Compounds*
Fluorodeoxyglucose F18*
Radiopharmaceuticals*
Thiazoles*
Alzheimer Disease/*diagnostic imaging
Brain/*diagnostic imaging
Frontotemporal Dementia/*diagnostic imaging
Plaque, Amyloid/*diagnostic imaging
Positron-Emission Tomography/*methods
Adult ; Aged ; Aged, 80 and over ; Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Amyloid beta-Peptides/metabolism ; Autopsy ; Brain/metabolism ; Brain/pathology ; DNA-Binding Proteins/metabolism ; Female ; Frontotemporal Dementia/metabolism ; Frontotemporal Dementia/pathology ; Frontotemporal Lobar Degeneration/diagnostic imaging ; Frontotemporal Lobar Degeneration/metabolism ; Frontotemporal Lobar Degeneration/pathology ; Humans ; Male ; Middle Aged ; Pick Disease of the Brain/diagnostic imaging ; Pick Disease of the Brain/metabolism ; Pick Disease of the Brain/pathology ; Plaque, Amyloid/metabolism ; Plaque, Amyloid/psychology ; Sensitivity and Specificity ; tau Proteins/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Counterpoint-No, Not So Fast!
Autorzy :: Moradi F; Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, 300 Pasteur Dr, H2200, Stanford, CA 94305.
Iagaru A; Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, 300 Pasteur Dr, H2200, Stanford, CA 94305.; Pokaż więcej
Źródło :: AJR. American journal of roentgenology [AJR Am J Roentgenol] 2021 Feb; Vol. 216 (2), pp. 307-308. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :: Journal Article
MeSH Terms :: Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals*
Gelatinases/*antagonists & inhibitors
Gelatinases/*metabolism
Membrane Proteins/*antagonists & inhibitors
Membrane Proteins/*metabolism
Neoplasms/*diagnostic imaging
Serine Endopeptidases/*metabolism
Biomarkers/metabolism ; Humans ; Neoplasms/metabolism ; Sensitivity and Specificity
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome.
Autorzy :: Dietz M; Nuclear Medicine Department, Centre Hospitalier Princesse Grace, 1 Avenue Pasteur, 98000, Monaco, Monaco.
Chironi G; Check-up Unit, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Claessens YE; Department of Emergency Medicine, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Farhad RL; Pulmonary Department, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Rouquette I; Department of Intensive Care Medicine, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Serrano B; Medical Physics Department, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Nataf V; Nuclear Medicine Department, Centre Hospitalier Princesse Grace, 1 Avenue Pasteur, 98000, Monaco, Monaco.
Hugonnet F; Nuclear Medicine Department, Centre Hospitalier Princesse Grace, 1 Avenue Pasteur, 98000, Monaco, Monaco.
Paulmier B; Nuclear Medicine Department, Centre Hospitalier Princesse Grace, 1 Avenue Pasteur, 98000, Monaco, Monaco.
Berthier F; Department of Biostatistics, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Keita-Perse O; Infection disease Department, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Giammarile F; Division of Human Health, International Atomic Energy Agency, Vienna, Austria.; Centre Leon Berard, Lyon, France.
Perrin C; Pulmonary Department, Centre Hospitalier Princesse Grace, Monaco, Monaco.
Faraggi M; Nuclear Medicine Department, Centre Hospitalier Princesse Grace, 1 Avenue Pasteur, 98000, Monaco, Monaco. .; Pokaż więcej
Corporate Authors :: MONACOVID Group
Źródło :: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Jan; Vol. 48 (1), pp. 260-268. Date of Electronic Publication: 2020 Jul 25.
Typ publikacji :: Clinical Trial; Journal Article
MeSH Terms :: Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals*
COVID-19/*diagnostic imaging
Aged ; Aged, 80 and over ; COVID-19/classification ; COVID-19/therapy ; Female ; Heart/diagnostic imaging ; Humans ; Inflammation/diagnostic imaging ; Lung/diagnostic imaging ; Lymph Nodes/diagnostic imaging ; Male ; Middle Aged ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Liver Function Changes After Technetium-99m-Macroaggregated Albumin Administration and Their Predictive Value Regarding Hepatotoxicity in Patients Undergoing Yttrium-90-Radioembolization.
Autorzy :: Fabritius MP; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Hartmann F; Otto-von-Guericke Universitätsklinikum, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Magdeburg, Germany.
Seidensticker R; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Pech M; Otto-von-Guericke Universitätsklinikum, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Magdeburg, Germany.
Powerski M; Otto-von-Guericke Universitätsklinikum, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Magdeburg, Germany.
Grosu S; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Maurus S; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Todica A; Department of Nuclear Medicine, University Hospital, University Hospital, LMU Munich, Munich, Germany.
Ilhan H; Department of Nuclear Medicine, University Hospital, University Hospital, LMU Munich, Munich, Germany.
Omari J; Otto-von-Guericke Universitätsklinikum, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Magdeburg, Germany.
Damm R; Otto-von-Guericke Universitätsklinikum, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Magdeburg, Germany.
GROßER O; Otto-von-Guericke Universitätsklinikum, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Magdeburg, Germany.
Albers J; Klinik für Nuklearmedizin, Charite, Berlin, Germany.
Ricke J; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Seidensticker M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany; .; Pokaż więcej
Źródło :: Anticancer research [Anticancer Res] 2021 Jan; Vol. 41 (1), pp. 437-444.
Typ publikacji :: Journal Article
MeSH Terms :: Chemical and Drug Induced Liver Injury/*diagnosis
Chemical and Drug Induced Liver Injury/*etiology
Embolization, Therapeutic/*adverse effects
Liver Neoplasms/*complications
Liver Neoplasms/*therapy
Radiopharmaceuticals/*adverse effects
Technetium Tc 99m Aggregated Albumin/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Computed Tomography Angiography ; Disease Management ; Embolization, Therapeutic/methods ; Female ; Humans ; Liver Function Tests ; Male ; Middle Aged ; Prognosis ; Radiopharmaceuticals/administration & dosage ; Retrospective Studies ; Technetium Tc 99m Aggregated Albumin/administration & dosage ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: CT abnormalities evocative of lung infection are associated with lower F-FDG uptake in confirmed COVID-19 patients.
Autorzy :: Bahloul A; Lorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.
Boursier C; Lorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.
Jeulin H; Lorraine University, Department of Virology, CHRU Nancy, F-54000, Nancy, France.
Imbert L; Lorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.; Lorraine University, IADI, INSERM U1254, F-54000, Nancy, France.
Mandry D; Lorraine University, IADI, INSERM U1254, F-54000, Nancy, France.; Lorraine University, Department of Radiology, Brabois, CHRU Nancy, F-54000, Nancy, France.
Karcher G; Lorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.
Marie PY; Lorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.; Lorraine University, DCAC, INSERM U1116, F-54000, Nancy, France.
Verger A; Lorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France. .; Lorraine University, IADI, INSERM U1254, F-54000, Nancy, France. .; Pokaż więcej
Źródło :: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Jan; Vol. 48 (1), pp. 282-286. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :: Journal Article
MeSH Terms :: Fluorodeoxyglucose F18*
Radiopharmaceuticals*
COVID-19/*diagnostic imaging
Lung/*diagnostic imaging
Positron Emission Tomography Computed Tomography/*methods
Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19 Nucleic Acid Testing ; COVID-19 Serological Testing ; Diagnosis, Differential ; Female ; Humans ; Male ; Middle Aged ; Positron Emission Tomography Computed Tomography/standards
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Imaging in Differentiating Cerebral Toxoplasmosis and Primary CNS Lymphoma With Special Focus on FDG PET/CT.
Autorzy :: Marcus C; Department of Radiology, West Virginia University, 1 Medical Center Dr, Morgantown, WV 26505.
Feizi P; Department of Neuroradiology, West Virginia University, Morgantown, WV.
Hogg J; Department of Neuroradiology, West Virginia University, Morgantown, WV.
Summerfield H; Department of Infectious Diseases, West Virginia University, Morgantown, WV.
Castellani R; Department of Pathology, West Virginia University, Morgantown, WV.
Sriwastava S; Department of Neurology, West Virginia University, Morgantown, WV.
Marano GD; Department of Radiology, West Virginia University, 1 Medical Center Dr, Morgantown, WV 26505.; Pokaż więcej
Źródło :: AJR. American journal of roentgenology [AJR Am J Roentgenol] 2021 Jan; Vol. 216 (1), pp. 157-164. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals*
Brain Neoplasms/*diagnostic imaging
Lymphoma/*diagnostic imaging
Toxoplasmosis, Cerebral/*diagnostic imaging
Diagnosis, Differential ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Neuroimaging with Radiopharmaceuticals Targeting the Glutamatergic System.
Autorzy :: Mu L; Center for Radiopharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland; Center for Radiopharmaceutical Sciences, Department of Nuclear Medicine, University Hospital Zurich, CH-8091 Zurich, Switzerland;, Email: .
Krämer SD; Center for Radiopharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland.
Ahmed H; Center for Radiopharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland.
Gruber S; Center for Radiopharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland.
Geistlich S; Center for Radiopharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland.
Schibli R; Center for Radiopharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland; Center for Radiopharmaceutical Sciences, Department of Nuclear Medicine, University Hospital Zurich, CH-8091 Zurich, Switzerland.
Ametamey SM; Center for Radiopharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, CH-8093 Zurich, Switzerland;, Email: .; Pokaż więcej
Źródło :: Chimia [Chimia (Aarau)] 2020 Dec 23; Vol. 74 (12), pp. 960-967.
Typ publikacji :: Journal Article
MeSH Terms :: Brain*/diagnostic imaging
Radiopharmaceuticals*
Neuroimaging ; Positron-Emission Tomography ; Tissue Distribution
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Expanding the Chemistry Palette for Radiotracer Synthesis.
Autorzy :: Lamb J; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
d'Orchymont F; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Fay R; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Gribi F; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Flores JE; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Gut M; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Klingler S; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Pires P; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Bühler J; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Behmaneshfar S; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Guillou A; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Earley DF; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
Holland JP; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland;, Email: .; Pokaż więcej
Źródło :: Chimia [Chimia (Aarau)] 2020 Dec 23; Vol. 74 (12), pp. 946-952.
Typ publikacji :: Journal Article
MeSH Terms :: Radioisotopes*
Radiopharmaceuticals*
Chemistry Techniques, Synthetic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Targeted Radiotherapeutics from 'Bench-to-Bedside'.
Autorzy :: Müller C; Center for Radiopharmaceutical Sciences, Forschungsstrasse 111, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland.
Béhé M; Center for Radiopharmaceutical Sciences, Forschungsstrasse 111, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland.
Geistlich S; Center for Radiopharmaceutical Sciences, Forschungsstrasse 111, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland.
van der Meulen NP; Center for Radiopharmaceutical Sciences, Forschungsstrasse 111, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland; Laboratory of Radiochemistry, Forschungsstrasse 111, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland.
Schibli R; Center for Radiopharmaceutical Sciences, Forschungsstrasse 111, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland; Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prolog-Weg 1-5/10, CH-8093 Zurich, Switzerland;, Email: .; Pokaż więcej
Źródło :: Chimia [Chimia (Aarau)] 2020 Dec 23; Vol. 74 (12), pp. 939-945.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Neoplasms*/drug therapy
Neoplasms*/radiotherapy
Radiopharmaceuticals*
Humans ; Radioisotopes ; Switzerland ; Translational Medical Research
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Hydroxamate-Based Selective Macrophage Elastase (MMP-12) Inhibitors and Radiotracers for Molecular Imaging.
Autorzy :: Gona K; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Toczek J; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Ye Y; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Sanzida N; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Golbazi A; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Boodagh P; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Salarian M; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Jung JJ; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Rajendran S; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Kukreja G; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.
Wu TL; Yale West Campus Analytical Core, Yale University, West Haven, Connecticut 06516, United States.
Devel L; CEA, INRAE, Medicaments et Technologies pour la Sante (MTS), SIMoS, Université Paris-Saclay, 91191 Gif-sur-Yvette, France.
Sadeghi MM; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06511, United States.; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, United States.; Pokaż więcej
Źródło :: Journal of medicinal chemistry [J Med Chem] 2020 Dec 10; Vol. 63 (23), pp. 15037-15049. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :: Hydroxamic Acids/*pharmacology
Matrix Metalloproteinase 12/*metabolism
Matrix Metalloproteinase Inhibitors/*pharmacology
Oligopeptides/*pharmacology
Organotechnetium Compounds/*pharmacology
Radiopharmaceuticals/*pharmacology
Animals ; Aortic Aneurysm, Abdominal/enzymology ; Aortic Aneurysm, Abdominal/metabolism ; Drug Design ; Humans ; Hydroxamic Acids/chemical synthesis ; Matrix Metalloproteinase Inhibitors/chemical synthesis ; Mice, Inbred C57BL ; Molecular Imaging/methods ; Molecular Structure ; Oligopeptides/chemical synthesis ; Organotechnetium Compounds/chemical synthesis ; Radiopharmaceuticals/chemical synthesis ; Structure-Activity Relationship
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.
Autorzy :: Stahlie EHA; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
van der Hiel B; Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Stokkel MPM; Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Schrage YM; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Wouters MW; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
van Akkooi ACJ; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Pokaż więcej
Źródło :: Journal of surgical oncology [J Surg Oncol] 2020 Dec; Vol. 122 (7), pp. 1328-1336. Date of Electronic Publication: 2020 Aug 11.
Typ publikacji :: Journal Article
MeSH Terms :: Fluorodeoxyglucose F18*
Radiopharmaceuticals*
Melanoma/*surgery
Neoplasm Recurrence, Local/*diagnostic imaging
Positron Emission Tomography Computed Tomography/*methods
Aged ; Female ; Humans ; Male ; Melanoma/diagnostic imaging ; Melanoma/pathology ; Middle Aged ; Neoplasm Staging ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Yttrium-90 Radioembolization for Hepatocellular Carcinoma with Portal Vein Invasion: Validation of the Milan Prognostic Score.
Autorzy :: Bargellini I; Department of Interventional Radiology, Pisa University Hospital, via Paradisa 2, 56100 Pisa, Italy. Electronic address: .
Scalise P; Department of Interventional Radiology, Pisa University Hospital, via Paradisa 2, 56100 Pisa, Italy.
Boni G; Department of Nuclear Medicine, Pisa University Hospital, via Paradisa 2, 56100 Pisa, Italy.
Traino CA; Department of Health Physics, Pisa University Hospital, via Paradisa 2, 56100 Pisa, Italy.
Bozzi E; Department of Interventional Radiology, Pisa University Hospital, via Paradisa 2, 56100 Pisa, Italy.
Lorenzoni G; Department of Interventional Radiology, Pisa University Hospital, via Paradisa 2, 56100 Pisa, Italy.
Crocetti L; Department of Interventional Radiology, Pisa University Hospital, via Paradisa 2, 56100 Pisa, Italy.
Cioni R; Department of Interventional Radiology, Pisa University Hospital, via Paradisa 2, 56100 Pisa, Italy.; Pokaż więcej
Źródło :: Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2020 Dec; Vol. 31 (12), pp. 2028-2032. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji :: Journal Article; Validation Study
MeSH Terms :: Clinical Decision Rules*
Embolization, Therapeutic*/adverse effects
Carcinoma, Hepatocellular/*radiotherapy
Liver Neoplasms/*radiotherapy
Portal Vein/*pathology
Radiopharmaceuticals/*administration & dosage
Yttrium Radioisotopes/*administration & dosage
Aged ; Carcinoma, Hepatocellular/diagnostic imaging ; Carcinoma, Hepatocellular/pathology ; Clinical Decision-Making ; Female ; Humans ; Liver Neoplasms/diagnostic imaging ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Invasiveness ; Patient Selection ; Predictive Value of Tests ; Radiopharmaceuticals/adverse effects ; Reproducibility of Results ; Retrospective Studies ; Treatment Outcome ; Yttrium Radioisotopes/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Tc-Dextran Lymphoscintigraphy SPECT/CT Unveils the Hidden Leakage Site in Recurrent Chylothoraxes.
Autorzy :: Xia X; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Shao F; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
Hu F; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
He Y; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Cao W; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China. Electronic address: .; Pokaż więcej
Źródło :: The Annals of thoracic surgery [Ann Thorac Surg] 2020 Dec; Vol. 110 (6), pp. e465-e467. Date of Electronic Publication: 2020 Jun 03.
Typ publikacji :: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Dextrans*
Organotechnetium Compounds*
Radiopharmaceuticals*
Tomography, Emission-Computed, Single-Photon*/methods
Azygos Vein/*surgery
Chylothorax/*diagnostic imaging
Chylothorax/*surgery
Lymphoscintigraphy/*methods
Postoperative Complications/*surgery
Thoracic Duct/*surgery
Adult ; Female ; Humans ; Recurrence
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Transarterial Yttrium-90 Radioembolization of Hepatocellular Carcinoma Perfused by the Cystic Artery: Multi-institutional Feasibility Study.
Autorzy :: Padia SA; Division of Interventional Radiology, Department of Radiology, David Geffen School of Medicine at University of California, Los Angeles, 757 Westwood Plaza, Room 2125, Los Angeles, CA 90095. Electronic address: .
Johnson GE; Section of Interventional Radiology, Department of Radiology, University of Washington, Seattle, Washington.
Lewandowski RJ; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.
Gabr A; Section of Interventional Radiology, Department of Radiology, Northwestern University, Chicago, Illinois.
Toskich BB; Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, Florida.; Pokaż więcej
Źródło :: Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2020 Dec; Vol. 31 (12), pp. 2022-2027. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Embolization, Therapeutic*/adverse effects
Carcinoma, Hepatocellular/*blood supply
Carcinoma, Hepatocellular/*surgery
Gallbladder/*blood supply
Liver Neoplasms/*blood supply
Liver Neoplasms/*drug therapy
Radiopharmaceuticals/*administration & dosage
Yttrium Radioisotopes/*administration & dosage
Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/diagnostic imaging ; Feasibility Studies ; Female ; Humans ; Infusions, Intra-Arterial ; Liver Neoplasms/diagnostic imaging ; Male ; Middle Aged ; Radiopharmaceuticals/adverse effects ; Retrospective Studies ; Treatment Outcome ; United States ; Yttrium Radioisotopes/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Diagnostic value of axillary artery ultrasound in patients with suspected giant cell arteritis.
Autorzy :: Hop H; Department of Internal Medicine, Division of Vascular Medicine.
Mulder DJ; Department of Internal Medicine, Division of Vascular Medicine.
Sandovici M; Department of Rheumatology and Clinical Immunology.
Glaudemans AWJM; Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen.
van Roon AM; Department of Internal Medicine, Division of Vascular Medicine.
Slart RHJA; Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen.; Department of Biomedical Photonic Imaging, University of Twente, Enschede, The Netherlands.
Brouwer E; Department of Rheumatology and Clinical Immunology.; Pokaż więcej
Źródło :: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Dec 01; Vol. 59 (12), pp. 3676-3684.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*/methods
Radiopharmaceuticals*
Ultrasonography, Doppler, Color*
Axillary Artery/*diagnostic imaging
Giant Cell Arteritis/*diagnostic imaging
Temporal Arteries/*diagnostic imaging
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Radiopharmaceuticals"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język